NCT05436522View on ClinicalTrials.gov

REmimazolam vs PrOpofol on Intraoperative hypotenSion in Major Noncardiac surgEry

PHASE4CompletedINTERVENTIONAL
Enrollment

340

Participants

Timeline

Start Date

August 22, 2022

Primary Completion Date

May 21, 2024

Study Completion Date

June 21, 2024

Conditions
Intraoperative Hypotension
Interventions
DRUG

Remimazolam

Remimazolam is administered intravenously for induction and maintenance of general anesthesia. The dose is titrated to maintain Bispectral Index value between 40 and 60.

DRUG

Propofol

Propofol is administered intravenously for induction and maintenance of general anesthesia. The dose is titrated to maintain Bispectral Index value between 40 and 60.

Trial Locations (1)

510515

Nanfang Hospital, Southern Medical University, Guangzhou

All Listed Sponsors
lead

Nanfang Hospital, Southern Medical University

OTHER